Magnesium Aconitate

Magnesium aconitate is a magnesium salt of aconitic acid, a tricarboxylic acid intermediate in the citric acid (Krebs) cycle. No clinical trials or biomedical studies have evaluated its therapeutic efficacy or bioavailability in humans, making it one of the least-studied magnesium compounds available.

Origin & History

Magnesium aconitate is the magnesium salt of aconitic acid (C6H6O6), a tricarboxylic acid intermediate in the citric acid cycle, typically synthesized as magnesium aconitate hexahydrate through chemical preparation methods. While aconitic acid occurs naturally in sugar cane and citrus fruits, the magnesium salt is produced via chemical salt formation rather than direct plant extraction.

Historical & Cultural Context

No historical or traditional medicinal uses are recorded for magnesium aconitate in any traditional medicine systems including Ayurveda or TCM. Documentation is confined exclusively to chemical literature rather than medicinal applications.

Health Benefits

• No documented health benefits - no clinical trials or biomedical studies exist for magnesium aconitate
• No evidence for therapeutic effects - research limited to early 20th-century chemical studies
• No established medicinal uses - no safety or efficacy data available
• Potential magnesium source by analogy only - unstudied for biological activity
• No traditional medicinal applications recorded in any system

How It Works

Magnesium aconitate theoretically dissociates in the gastrointestinal tract to release free magnesium ions (Mg²⁺) and aconitate, a tricarboxylic acid anion. Mg²⁺ acts as a cofactor for over 300 enzymatic reactions, including ATP synthase, adenylyl cyclase, and NMDA receptor modulation. The aconitate ligand is a substrate in the citric acid cycle, converted by aconitase (ACO2) between citrate and isocitrate, though whether dietary aconitate meaningfully contributes to this pathway after oral ingestion has not been studied.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for magnesium aconitate in available sources, including PubMed searches that yielded no PMIDs. Research is confined to early 20th-century chemical preparation studies with no biomedical efficacy data.

Clinical Summary

No clinical trials, randomized controlled studies, or prospective human studies have been conducted on magnesium aconitate as of the available literature. Published research is limited to early 20th-century organic chemistry characterizations of aconitic acid salts, with no measurement of bioavailability, pharmacokinetics, or health outcomes. Because no safety or efficacy data exist, it is impossible to draw evidence-based conclusions about its therapeutic potential or compare it to well-studied forms such as magnesium glycinate, citrate, or malate. The absence of data does not imply safety or benefit; it reflects a complete research gap.

Nutritional Profile

Magnesium aconitate is the magnesium salt of aconitic acid (propene-1,2,3-tricarboxylic acid), contributing both elemental magnesium and the tricarboxylate aconitate anion. The magnesium content by molecular weight is approximately 10-12% elemental magnesium (molecular formula approximated as C6H4MgO6, MW ~196), comparable in elemental density to magnesium citrate (~11%) rather than magnesium oxide (~60%). Aconitic acid is an intermediate in the Krebs cycle, appearing between citrate and isocitrate via aconitase enzyme activity, suggesting the aconitate component is a naturally occurring organic acid in human metabolism. No direct bioavailability studies exist for this specific salt; however, by structural analogy to magnesium citrate and magnesium malate — other organic acid magnesium salts — bioavailability may exceed inorganic forms (oxide, sulfate) due to the chelating carboxylate groups enhancing solubility at intestinal pH. No fiber, protein, or vitamin content is present. The aconitate ligand itself contributes no established caloric or micronutrient value beyond its role as an organic acid carrier.

Preparation & Dosage

No clinically studied dosage ranges exist for magnesium aconitate, as no clinical studies have been conducted. No standardized forms, extracts, or preparations have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Magnesium aconitate may pair meaningfully with Vitamin B6 (pyridoxine, 10-25mg), which upregulates magnesium transport into cells and reduces urinary magnesium excretion, amplifying intracellular magnesium retention regardless of the salt form used. Given that aconitate is a Krebs cycle intermediate, co-administration with malic acid or magnesium malate could theoretically support mitochondrial energy flux by providing sequential intermediates to aconitase and malate dehydrogenase pathways, potentially benefiting individuals with mitochondrial insufficiency. Taurine (500-1000mg) represents a third complementary pairing, as taurine stabilizes intracellular magnesium concentrations by modulating membrane ion channels and has demonstrated additive effects with magnesium salts in cardiovascular and neuromuscular applications in preclinical studies.

Safety & Interactions

No formal safety studies, toxicology data, or adverse event reports specific to magnesium aconitate exist in the published literature. General magnesium toxicity risk applies: excessive magnesium intake from any supplemental source can cause hypermagnesemia, presenting as diarrhea, nausea, hypotension, bradycardia, and in severe cases, cardiac arrest, particularly in individuals with renal impairment. Magnesium supplementation broadly may interact with bisphosphonates, fluoroquinolone and tetracycline antibiotics, and certain diuretics by impairing absorption or altering excretion. Pregnant or breastfeeding individuals should avoid magnesium aconitate specifically due to the complete absence of safety data, though magnesium itself is essential during pregnancy.